![](/img/cover-not-exists.png)
443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population
Gomez-Roca, C A, Garralda-Cabanas, E, Cruzalegui, F, Ausseil, F, Zorza, G, Delfour, O, Besse, J, Akla, B, Gautier, S, Adam, J, Lacroix-Triki, M, Passioukov, A, Roche, R, Pavlyuk, M, Massard, CVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy279.430
Date:
October, 2018
File:
PDF, 93 KB
english, 2018